open access
Nonsteroidal anti-inflammatory drugs (NSAIDs) in COVID-19 patient
Affiliations- Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy, Warsaw, Poland
open access
Abstract
Abstract
Keywords
COVID-19, SARS-CoV-2, treatment; fever, nonsteroidal anti-inflammatory drugs, NSAIDs
About this articleTitle
Nonsteroidal anti-inflammatory drugs (NSAIDs) in COVID-19 patient
Journal
Disaster and Emergency Medicine Journal
Issue
Article type
Letter to the Editor
Pages
108-109
Published online
2020-04-14
Page views
800
Article views/downloads
1321
DOI
Bibliographic record
Disaster Emerg Med J 2020;5(2):108-109.
Keywords
COVID-19
SARS-CoV-2
treatment
fever
nonsteroidal anti-inflammatory drugs
NSAIDs
Authors
Michal Paprocki
References (8)- Smereka J, Szarpak L, Filipiak KJ. Modern medicine in COVID-19 era. Disaster Emerg Med J. ; 2020.
- Lake MA. What we know so far: COVID-19 current clinical knowledge and research. Clin Med (Lond). 2020; 20(2): 124–127.
- Ruetzler K, Szarpak L, Filipiak KJ, et al. The COVID-19 pandemic — a view of the current state of the problem. Disaster Emerg Med J. ; 2020.
- Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020; 8(4): e21.
- Liu Z, Xiao X, Wei X, et al. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol. 2020 [Epub ahead of print].
- Day M. Covid-19: European drugs agency to review safety of ibuprofen. BMJ. 2020; 368: m1168.
- Sodhi M, Etminan M. Safety of Ibuprofen in Patients with COVID-19; Causal or Confounded? Chest. 2020 [Epub ahead of print].
- Gupta R, Misra A. Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc). Diabetes Metab Syndr. 2020 [Epub ahead of print]; 14(3): 251–254.